Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma Between February 2008 and August 2020, 165 patients were randomly assigned 1:1 to receive ...
Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate ...
Please provide your email address to receive an email when new articles are posted on . Survival outcomes did not differ for patients with HNSCC who received radiotherapy with carboplatin-paclitaxel ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Investigators conducted a network meta-analysis of phase 3 trials on MIBC treatments to provide comparative ranking of perioperative therapies.
Patients typically experience a modest mean 8.1 mL/min/1.73 m2 decrease in the eGFR after cisplatin treatment. A simple regression model based on the pretreatment estimated glomerular filtration rate ...
Beyond this study population, there are ongoing randomized trials evaluating NBTXR3 for definitive treatment of HNSCC, ...
Induction chemotherapy followed by chemoradiotherapy improves five-year progression-free and overall survival rates in locally advanced cervical cancer patients. The induction chemotherapy regimen led ...
Patients with human papillomavirus (HPV)-positive (HPV+) head and neck cancers who respond to induction chemotherapy can subsequently be treated safely and effectively with a substantially lower ...
MedPage Today on MSN
'Remarkable' Survival Outcomes in Cisplatin-Ineligible Bladder Cancer
The perioperative enfortumab vedotin plus pembrolizumab (EV-P) substantially increased the frequency of adverse events (AEs), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results